Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.58 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.58 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4638947 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL60846 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL7188409 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2695072 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL62052 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL418810 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2693656 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL632447 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL905578 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL60424 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-2999329-B1 | LYSOPHOSPHOLIPIDS AND ALKYL-LYSOPHOSPHOLIPIDS AGAINST HONEYBEE BROOD DISEASES | UNIV OF GRAZ (AT) | 2018-04-11 | — | — | EP | claimed |
| EP-2451460-B1 | LIQUID PHARMACEUTICAL FORM OF HEXADECYLPHOSPHOCHOLINE AND METHOD OF PREPARING SAME | MENG PAUL (AT) | 2017-10-25 | — | — | EP | claimed |
| US-20160106768-A1 | LYSOPHOSPHOLIPIDS AND LYSOPHOSPHOLIPID ANALOGUES AGAINST HONEYBEE BROOD DISEASES | UNIVERSITY OF GRAZ (AT) | 2016-04-21 | — | — | US | claimed |
| EP-2999329-A1 | LYSOPHOSPHOLIPIDS AND LYSOPHOSPHOLIPID ANALOGUES AGAINST HONEYBEE BROOD DISEASES | University of Graz (AT) | 2016-03-30 | — | — | EP | claimed |
| EP-1536770-B1 | THERMOLABILE LIPOSOME WITH A CONTROLLED RELEASE TEMPERATURE | MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V (DE) | 2015-07-29 | — | — | EP | claimed |
| EP-2028940-A2 | ALKYLPHOSPHOLIPIDS AS ACTIVE AGENTS FOR PREVENTION OF PLANT PATHOGENS | Staatliches Weinbauinstitut Freiburg (DE) | 2009-03-04 | — | — | EP | claimed |
| WO-2007147875-A2 | ALKYLPHOSPHOLIPIDS AS ACTIVE AGENTS FOR PREVENTION OF PLANT PATHOGENS | STAATLICHES WEINBAUINSTITUT FREIBURG (DE) | 2007-12-27 | — | — | WO | claimed |
| EP-1869981-A1 | Alkylphospholipids and lysophospholipids for controlling plant pathogens | Staatliches Weinbauinstitut Freiburg (DE) | 2007-12-26 | — | — | EP | claimed |
| EP-1355660-B1 | COMPOSITION AND KIT FOR USE IN THE TREATMENT OF TUMORS | BIOTHER CORP (US) | 2007-07-25 | — | — | EP | claimed |
| EP-1135193-B1 | AGENTS PROVIDED FOR TREATING TUMORS, BASED ON LIPOSOMES, AND CONTAINING TAMOXIFEN | MAX DELBRUECK CENTRUM (DE) | 2002-10-30 | — | — | EP | claimed |
| EP-1135193-A1 | AGENTS PROVIDED FOR TREATING TUMORS, BASED ON LIPOSOMES, AND CONTAINING TAMOXIFEN | MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (DE) | 2001-09-26 | — | — | EP | claimed |
| WO-2000033917-A1 | AGENTS PROVIDED FOR TREATING TUMORS, BASED ON LIPOSOMES, AND CONTAINING TAMOXIFEN | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 2000-06-15 | — | — | WO | claimed |
| EP-0796085-B1 | SOLUBILISATION AIDS FOR HYDROPHILIC MACROMOLECULES | PROVALIS UK LTD (GB) | 2000-05-17 | — | — | EP | claimed |
| EP-0393575-B1 | Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent | SEARLE & CO (US) | 1994-03-16 | — | — | EP | claimed |
| EP-0359981-B1 | PHARMACEUTICAL COMBINATIONS AND THEIR USE AS ANTINEOPLASTIC MEDICINES | Roche Diagnostics GmbH (DE) | 1993-07-28 | — | — | EP | claimed |
| EP-0248047-B1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1991-06-19 | — | — | EP | claimed |
| EP-0248047-A1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE. | MAX PLANCK GESELLSCHAFT (DE) | 1987-12-09 | — | — | EP | claimed |
| EP-0230575-A2 | Medicament active against tumours, containing hexadecylphosphocholine | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-08-05 | — | — | EP | claimed |
| WO-1987003480-A2 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | claimed |